ClinicalTrials.gg
RecruitingNCT07620990MIND-HDUpdated Jun 2, 2026

Mindfulness Meditation in Hemodialysis Patients

An interventional study of Mindfulness Meditation Program and Routine Care in Hemodialysis, Stress and Sleep Quality, sponsored by Cyprus Aydin University. Recruiting at 4 sites in Cyprus. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-06-02.

Sponsored by Cyprus Aydin University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Apr 2026; still recruiting 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This randomised controlled study aims to evaluate the effects of mindfulness meditation on sleep quality, perceived stress and symptoms levels ion hemodialysis patients. Participants in the intervention group will receive a 4 week mindfulness meditation program in addition to routine care. Outcomes will be assessed before and after the intervention using validated measurement tools.

Read the detailed description

This study is designed as a randomized controlled experimental trial conducted in hemodialysis units in Northern Cyprus. Hemodialysis patients will be randomly assigned to intervention and control groups.The intervention group will participane in a structured 4 week mindfulness meditation program delivered through guided sessions, while the control group will continue receiving routine care. The study aims to determine the effectiveness of mindfulness meditation on sleep quality, stress levels and symptoms management in hemodialysis patients. Data will be collected before and after the intervention using validated assessment scales.

02

Conditions studied

  • Hemodialysis
  • Stress
  • Sleep Quality
  • Symptom

Keywords

  • Mindfulness Meditation
  • Hemodialysis
  • Sleep Quality
  • Stress
  • Symptom
03

In context

Sleep Initiation and Maintenance Disorders

2,722 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 726 are open to participants now.

This study's planned enrollment of 50 is below the median of 68 across 2,350 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

Cyprus Aydin University is the lead sponsor of 3 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged between 18 and 75 years
  • Patients receiving hemodialysis treatment for at least 3 months
  • Patients with cognitive functions suitable for the intervention (dementia score ≥21)
  • Patient without hearing, vision or communication problems
  • Patients without a psychiatric diagnosis
  • Patients able to use a smartphone or tablet
  • Patients not participating in another study
  • Patients not using sleep medication or antipsychotic drugs

Exclusion criteria

Exclusion Criteria:

  • Patients younger than 18 years or older than 75 years
  • Patients receiving hemodialysis treatment for less than 3 months
  • Patients with cognitive impairment unsuitable for the intervention (dementia score ≤21)
  • Patient with hearing, vision or communication disabilities
  • Patients diagnosed with psychiatric disorders
  • Patients unable to use a smartphone or tablet
  • Patients participating in another study
  • Patients using sleep medication or antipsychotic drugs
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Mindfulness Meditation Group

    Participants in this group will receive a 4 week meditation program in addition to routine hemodialysis care.

    Behavioral: Mindfulness Meditation Program

  • Other
    Control Group

    Participants in this group will receive rouyine hemodialysis care without mindfulness meditation intervention.

    Other: Routine Care

Interventions

  • BehavioralMindfulness Meditation Program

    Participants in the intervention group will receive a 4 week mindfulness meditation program consisting of weekly guided mindfulness sessions and home practices. The program is designed to improve sleep quality, reduce stress levels, and manage symptoms in hemodialysis patients.

  • OtherRoutine Care

    Participants in the control group will receive routine care provided in the hemodialysis unit without mindfulness meditation intervention.

06

What researchers measure

Primary outcomes

  1. Pittsburgh Sleep Quality İndex (PSQİ) Score

    Pittsburgh Sleep Quality İndex (PSQİ) will be used to assess sleep quality in hemodialysis patients receiving mindfulness meditation intervention. The total PSQİ score ranges from 0 to 21, with higher scores indicating poorer sleep quality.

    Time frame: Baseline and 4 weeks after intervention

  2. Perceived Stress Scale (PSS) Score

    The Perceived Stress Scale (PSS) will be used to assess stress levels in hemodialysis patients receiving mindfulness meditation intervention. Scores range from 0 to 40, with higher scores indicating higher perceived stress.

    Time frame: Baseline and 4 week after intervention.

  3. Dialysis Symptom İndex (DSİ)

    TheDialysis Symptom İndex (DSİ) will be used to assess symptom burden in hemodialysis patients receiving mindfulness meditation intervention. The total score ranges from 0 to 150, with higher scores indicating greater symptom burden.

    Time frame: Baseline and 4 weeks after intervention.

07

Study locations

4 of 4 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — Individual participant data sharing has not yet been determined.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07620990
Lead sponsor
Cyprus Aydin University
Responsible party
Sevda Şahin (RN, PhD Candidate, Cyprus Aydin University) — Principal investigator
First posted
Jun 2, 2026
Start date
Apr 15, 2026
Primary completion
Jul 2026 (estimated)
Completion
Aug 2026 (estimated)
Last update
Jun 2, 2026

Study contacts

Sevda Sahin, RN, PhD Candidate
Contact
sevda0584@hotmail.com
+905488488005
Sevda Sahin, RN, PhD Candidate
principal investigator · Cyprus Aydin University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion